Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Huapu Bio

Huapu Bio
2001 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Provider of drug development services intended to focus on development of drugs required for cancer treatment. The company's drug development services focus on biotechnology related research and development programs required to produce drugs which can be used for prevention of cancer and treatment of various infectious and autoimmune diseases, enabling its clients to receive biopharmaceutical products that targets toll-like receptors required to address serious medical needs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Sun Tong Infoport Plaza
  • 55 West Huaihai Road
  • Shanghai, Xuhui District 200072
  • China

+86 021 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Huapu Bio’s full profile, request a free trial.

Huapu Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC Completed Generating Revenue
1. Grant Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Huapu Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cenova Capital Venture Capital Minority 000 0000 000000 0
SBI Holdings PE/Buyout Minority 000 0000 000000 0

Huapu Bio Executive Team (5)

Name Title Board
Seat
Contact
Info
Dapeng Qian Ph.D Chief Executive Officer
Ligong Wang Chief Operating Officer, Operations & Co-Founder
Jianzhu Chen Ph.D Scientific Co-Founder
Yongjun Liu Ph.D Scientific Co-Founder
Tao Huang Ph.D Chief Legal Officer